These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23768748)

  • 41. Cost-effectiveness of the highly effective direct-acting antivirals in the treatment of chronic hepatitis C in Hong Kong.
    Lo AO; Chan HL; Wong VW; Wong GL
    J Gastroenterol Hepatol; 2017 May; 32(5):1071-1078. PubMed ID: 28449343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response].
    Zeuzem S
    MMW Fortschr Med; 2002 Feb; 144(8):30-4. PubMed ID: 11910820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
    [No Abstract]   [Full Text] [Related]  

  • 44. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
    Hunyady B; Kovács B; Battyáni Z
    Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probable boceprevir-induced hyponatremia in a patient with chronic hepatitis C.
    Hedrick KT; Just SM; Kahn DR
    Am J Health Syst Pharm; 2015 Mar; 72(6):449-52. PubMed ID: 25736938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in hepatitis C Virus And HIV co-infection.
    Plosker GL; Keating GM
    Drugs; 2004; 64(24):2823-43. PubMed ID: 15563253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection.
    Ferenci P; Reddy KR
    Antivir Ther; 2011; 16(8):1187-201. PubMed ID: 22155901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient].
    Montes ML; Fraile JM; González JJ; Arribas JR
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):60-1. PubMed ID: 19218008
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.
    Nasta P; Maida I; Cattelan AM; Pontali E; Angeli E; Giralda M; Verucchi G; Caputo A; Iannacone C; Puoti M; Carosi G
    J Womens Health (Larchmt); 2015 Feb; 24(2):159-64. PubMed ID: 25682817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Healing of chronic hepatitis C following 12 weeks of therapy with peginterferon-alpha and ribavirin].
    Barreales M; Castellano G; Fernández I; Muñoz R; Manzano M; Solís Herruzo JA
    Rev Esp Enferm Dig; 2007 Dec; 99(12):738-40. PubMed ID: 18290706
    [No Abstract]   [Full Text] [Related]  

  • 51. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.
    Pungpapong S; Aqel BA; Koning L; Murphy JL; Henry TM; Ryland KL; Yataco ML; Satyanarayana R; Rosser BG; Vargas HE; Charlton MR; Keaveny AP
    Liver Transpl; 2013 Jul; 19(7):690-700. PubMed ID: 23696372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pharmacokinetic evaluation of boceprevir for treatment of hepatitis C virus.
    Shankar H; Bichoupan K; Dieterich DT
    Expert Opin Drug Metab Toxicol; 2013 Dec; 9(12):1647-57. PubMed ID: 24079600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The "pegylated" story continues--perhaps because both ends (α2a and α2b) are true?
    Reiberger T; Peck-Radosavljevic M
    J Hepatol; 2012 Jul; 57(1):226-8; author reply 229. PubMed ID: 22390901
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.
    Mandorfer M; Payer BA; Niederecker A; Lang G; Aichelburg MC; Strassl R; Boesecke C; Rieger A; Trauner M; Peck-Radosavljevic M; Reiberger T
    AIDS Patient Care STDS; 2014 May; 28(5):221-7. PubMed ID: 24796757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress on the treatment of hepatitis C.
    Nierengarten MB
    Lancet Infect Dis; 2003 Dec; 3(12):748. PubMed ID: 14664249
    [No Abstract]   [Full Text] [Related]  

  • 56. Seizures in patients with chronic hepatitis C treated with NS3/4A protease inhibitors: does pharmacological interaction play a role?
    Milazzo L; Falvella FS; Magni C; Gervasoni C; Peri AM; Cattaneo D; Antinori S; Vidale S
    Pharmacology; 2013; 92(5-6):235-7. PubMed ID: 24192929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C.
    Dai CY; Huang CF; Chuang WL; Huang JF; Yu ML
    Am J Gastroenterol; 2009 Sep; 104(9):2358-9. PubMed ID: 19727098
    [No Abstract]   [Full Text] [Related]  

  • 58. Telaprevir (Incivek) and boceprevir (Victrelis) for chronic hepatitis C.
    Med Lett Drugs Ther; 2011 Jul; 53(1369):57-9. PubMed ID: 21778964
    [No Abstract]   [Full Text] [Related]  

  • 59. [Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].
    Hokari A
    Nihon Rinsho; 2011 May; 69 Suppl 4():196-200. PubMed ID: 22096918
    [No Abstract]   [Full Text] [Related]  

  • 60. Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study.
    Montes ML; Nelson M; Girard PM; Sasadeusz J; Horban A; Grinsztejn B; Zakharova N; Rivero A; Durant J; Ortega-Gonzalez E; Lathouwers E; Janssen K; Ouwerkerk-Mahadevan S; Witek J; González-García J
    J Antimicrob Chemother; 2016 Jan; 71(1):244-50. PubMed ID: 26483516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.